Skip to main content

MoneyWorks4Me

Novelix Pharmaceuticals informs about disclosure

02 Jun 2026 Evaluate
Novelix Pharmaceuticals has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srindhi Fine Chemicals LLP. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 366.60
Adani Enterprises 2705.00
Amrapali Industries 35.44
Maxgrow India 179.40
Rashi Peripheral 846.30
View more..